Glaxosmithkline Pharmaceuticals ... vs Zee Laboratories Limited

Case Significance

Glaxosmithkline Pharmaceuticals ... vs Zee Laboratories Limited is a Delhi High Court decision dated February 28, 2026 (citation: ik-131503643). GlaxoSmithKline filed a suit for trademark infringement, passing off and injunction against Zee Laboratories for using marks 'FEXIN', 'FEXIT', 'FEXIT-B' and 'FEXIT-M' deceptively similar to its registered trademark 'PHEXIN' for pharmaceutical products. The defendant discontinued 'FEXIN' by consent, but contested injunction against 'FEXIT' marks. The Court granted interim injunction restraining the defendant from using all impugned marks, finding a case of triple identity — deceptively similar The case was heard by Justice Tejas Karia. Counsel appearing: Hansika Bajaj (counsel for plaintiff), Rohit Bohra (counsel for defendant), Ruchika Yadav (counsel for plaintiff), Siddharth Bambha (counsel for defendant), Tanya Varma (counsel for plaintiff), Vardaan Anand (counsel for plaintiff).